Bezafibrate (Compound)

Synonyms:bezafibrate, 41859-67-0, Bezalip, Cedur, Bezafibrat, Befizal, Sklerofibrat, Azufibrat, Bezatol, Bezafibratum, Bezafibrato, Bezafibratum [INN-Latin], Bezafibrato [INN-Spanish], Bezatol SR (TN), BM-15.075, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid, UNII-Y9449Q51XH, Difaterol, 2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid, BM 15.075, 2-[4-[2-(4-Chlorobenzamido)ethyl]phenoxy]-2-methylpropanoic acid, BM15075, BM-15075, MLS000028533, CHEMBL264374, durabezur, Reducterol, Bezabeta, Bezacur, Bezamerck, Eulitop, Solibay, CHEBI:47612, Lipox, Bezafibrat PB, Y9449Q51XH, Beza-Lande, Beza-Puren, Regadrin B, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-propanoic acid, Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, Propanoic acid, 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methyl-, MFCD00078970, NCGC00016850-01, SMR000058298, Bezafibrato [Spanish], Bezalip Retard, CAS-41859-67-0, DSSTox_CID_9869, Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, DSSTox_RID_78826, DSSTox_GSID_29869, 2-(4-(2-(4-Chlorobenzamido)ethyl)phenoxy)-2-methylpropanoic acid, 2-{4-[2-(4-chlorobenzamido)ethyl]phenoxy}-2-methylpropanoic acid, LO 44, 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid, 2-(4-{2-[(4-chlorophenyl)formamido]ethyl}phenoxy)-2-methylpropanoic acid, 2-[P-[2-P-CHLOROBENZAMIDO)ETHYL]PHENOXY]-2-METHYLPROPIONIC ACID, BF-759, CCRIS 9085, BM 15075, SR-01000000106, EINECS 255-567-9, BRN 4267656, Bezalip SR, Bezafibrate,(S), Bezafibrate [USAN:INN:BAN:JAN], PEM, Prestwick_724, BENAFIBRATE, Spectrum_001443, Opera_ID_376, Prestwick0_000378, Prestwick1_000378, Prestwick2_000378, Prestwick3_000378, Spectrum2_000922, Spectrum3_001500, Spectrum4_000325, Spectrum5_001079, Spectrum5_001967, SCHEMBL16299, Bezafibrate-d6(dimethyl-d6), BSPBio_000535, BSPBio_001314, BSPBio_003119, KBioGR_000034, KBioGR_000669, KBioSS_000034, KBioSS_001923, MLS001148205, Bezafibrate, >=98%, solid, DivK1c_000092, SPECTRUM1502046, SPBio_000824, SPBio_002456, BPBio1_000589, GTPL2668, DTXSID3029869, BDBM28701

Pubchem:PUBCHEM:39042

Id:39042

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Bezafibrate's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Bezafibrate.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Bezafibrate.

Results found

Linked to

	Label	Description
	BRD-K46018455-001-17-7 Substance (Entity type)	A Substance
	DCSTRUCT ID 00362 Collection (Entity type)	DrugPage Collection: (DrugCentralID:00362; PubChem_CID:39042, FILE=drugcentral_drug_00362.json)
	bezafibrate (a817060a-7f26-4d08-b189-87cb1875f5e6) Collection (Entity type)	Metadatata for bezafibrate
	bezafibrate negatively regulates FKBP4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate negatively regulates NVL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate positively regulates GLUL Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate positively regulates F2RL1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate positively regulates TYRP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate negatively regulates CNPY3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	bezafibrate negatively regulates SCGB2A1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS